<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-vaccines-07-00046">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bottero</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zurita</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Gaillard</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Carriquiriborde</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Martin Aispuro</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Elizagaray</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bartel</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Castuma</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hozbor</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Outer-membrane-vesicle-associated o antigen, a crucial component for protecting against bordetella parapertussis infection</article-title>
  <source>Front. Immunology</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>2501</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.02501</pub-id>
  <?supplied-pmid 30459769?>
  <pub-id pub-id-type="pmid">30459769</pub-id>
 </element-citation>
</ref>
